U.S. Consumer Durables Stock News

In recent days, PagSeguro Digital has drawn increased attention after multiple brokerage firms reiterated positive ratings and refreshed their views on the company. This cluster of supportive analyst opinions has reinforced broader market perception of PagSeguro Digital as a business with improving sentiment among research houses. We’ll now explore how this wave of optimistic analyst coverage could influence PagSeguro Digital’s investment narrative for investors. Uncover the next big...

Selective Insurance Group (SIGI) just wrapped up FY 2025 with fourth quarter revenue of US$1.36b and basic EPS of US$2.52, alongside trailing twelve month revenue of US$5.34b and EPS of US$7.48. Over recent periods, the company has seen quarterly revenue move from US$1.26b in Q4 2024 to US$1.36b in Q4 2025, with basic EPS across those same quarters shifting from US$1.52 to US$2.52. The trailing net profit margin is now 8.6% compared with 4.1% a year earlier, and earnings growth over the past...

If you are wondering whether Enterprise Products Partners is genuinely priced for its strengths or if the market is overlooking something, you are exactly who this valuation review is for. The units recently closed at US$33.19, with returns of 0.5% over 7 days, 3.5% over 30 days, 3.2% year to date, 8.9% over 1 year, 59.2% over 3 years and 127.0% over 5 years, which gives plenty of history for a closer look at value. Recent headlines around Enterprise Products Partners have mainly focused on...

H&R Block (NYSE:HRB) has appointed Geralyn R. Breig, Christian H. Charnaux, and Stephanie C. Plaines to its Board of Directors. The three executives bring experience in consumer branding, growth planning, finance, and digital business models. The appointments represent a material change in the company’s governance and leadership structure. H&R Block’s share price is currently $39.45, with a 1-year return of 26.4% and a 5-year return of 145.4%. In the nearer term, the stock shows a 1.5%...

Two Harbors Investment, NYSE:TWO, has released tax treatment details for its 2025 common and preferred dividend distributions. The company stated that no portion of these 2025 distributions is expected to be classified as excess inclusion income. This clarification is intended to guide shareholders as they prepare tax reporting for the 2025 calendar year. For current holders of NYSE:TWO, the update comes with the stock recently trading at $11.47 and showing a mix of short term volatility...

It's been a pretty great week for Washington Trust Bancorp, Inc. ( NASDAQ:WASH ) shareholders, with its shares surging...

Cullen/Frost Bankers (CFR) has just wrapped up FY 2025 with fourth quarter revenue of US$569.6 million and basic EPS of US$2.59, alongside net income of US$164.6 million and a reported net interest margin of 3.66%. Over the past few quarters the company has seen revenue move from US$520.2 million and EPS of US$2.37 in Q4 2024 to US$569.6 million and US$2.59 in Q4 2025. Trailing twelve month EPS stands at US$10.02 on revenue of about US$2.2 billion, and the current focus is on how durable...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

Trustmark Corporation ( NASDAQ:TRMK ) will increase its dividend from last year's comparable payment on the 15th of...

Gentherm Incorporated ( NASDAQ:THRM ), is not the largest company out there, but it saw significant share price...

The board of Stifel Financial Corp. ( NYSE:SF ) has announced that it will be paying its dividend of $0.51 on the 16th...

Those following along with NBT Bancorp Inc. ( NASDAQ:NBTB ) will no doubt be intrigued by the recent purchase of shares...

While Napco Security Technologies, Inc. ( NASDAQ:NSSC ) shareholders are probably generally happy, the stock hasn't had...

Consolidated Edison, Inc. ( NYSE:ED ) will increase its dividend from last year's comparable payment on the 16th of...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move up...

The board of Associated Banc-Corp ( NYSE:ASB ) has announced that it will pay a dividend of $0.24 per share on the 16th...

F.N.B. Corporation ( NYSE:FNB ) will pay a dividend of $0.12 on the 16th of March. This means the dividend yield will...

The board of RPC, Inc. ( NYSE:RES ) has announced that it will pay a dividend on the 10th of March, with investors...

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Becton, Dickinson and Company's ( NYSE:BDX ) investors are due to receive a payment of $1.05 per share on 31st of...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you are wondering whether Navient is priced attractively right now, the recent share moves and current valuation metrics give you quite a bit to think about. The stock recently closed at US$9.81, with returns of an 18.8% decline over 7 days, a 24.5% decline over 30 days, a 23.2% decline year to date and a 24.7% decline over the past year, alongside a 41.1% decline over 3 years and a 3.2% decline over 5 years. These moves have been unfolding against a backdrop of ongoing market attention...

Halliburton (NYSE:HAL) has launched the Next-Generation Energy Accelerators Joint Lab, known as NEX Lab, in collaboration with A*STAR in Singapore. The joint lab is focused on advanced well completion technologies and supporting energy transition efforts. NEX Lab is intended to expand research, engineering, and testing capabilities while supporting local talent development and low carbon solutions. For investors watching NYSE:HAL, this move comes with the stock at $33.52 and a 30 day return...

Sun Pharmaceutical has submitted a nonbinding offer to acquire Organon (NYSE:OGN). Organon recently received FDA approval for extended duration use of NEXPLANON with a new REMS safety program. These developments affect Organon’s women’s health portfolio and potential ownership structure. Organon, trading at $8.54, is coming into focus as both a deal target and a women’s health player with a newly approved product label. The share price is up 19.1% over the past 30 days and 18.0% year to...